Modern Retina Summer 2022
June 20, 2022
Article
A window into the world of academic retina practice today.
June 15, 2022
Article
Although off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.